ROSSARI, FEDERICO
 Distribuzione geografica
Continente #
EU - Europa 117
AS - Asia 59
NA - Nord America 36
SA - Sud America 2
Totale 214
Nazione #
IT - Italia 61
US - Stati Uniti d'America 34
SG - Singapore 25
HK - Hong Kong 16
CN - Cina 15
DE - Germania 15
NL - Olanda 12
AT - Austria 6
SE - Svezia 5
RU - Federazione Russa 4
CH - Svizzera 3
FI - Finlandia 3
BE - Belgio 2
BR - Brasile 2
GB - Regno Unito 2
LT - Lituania 2
CA - Canada 1
GR - Grecia 1
IE - Irlanda 1
IN - India 1
MX - Messico 1
PK - Pakistan 1
TH - Thailandia 1
Totale 214
Città #
Milan 21
Hong Kong 16
Singapore 12
Shanghai 9
Cesano Boscone 7
Berlin 6
Boardman 6
Ashburn 4
Monza 4
Nuremberg 4
Helsinki 3
Moscow 3
New York 3
Rome 3
Schafisheim 3
Vienna 3
Bologna 2
Brussels 2
Falkenstein 2
London 2
Lucca 2
Naples 2
Verona 2
Araras 1
Atlanta 1
Bangkok 1
Charlotte 1
Chicago 1
Dublin 1
Frankfurt am Main 1
Guangzhou 1
Inhaúma 1
Jiaxing 1
Kassel 1
Lawrence 1
Lazise 1
Lecce 1
Los Angeles 1
Mexico City 1
Princeton 1
Pune 1
Quanzhou 1
Rhodes 1
Romagnano Sesia 1
Seattle 1
Seregno 1
Toronto 1
Verdellino 1
Totale 146
Nome #
Targeted inducible delivery of immunoactivating cytokines reprograms glioblastoma microenvironment and inhibits growth in mouse models 77
Impact of body mass index on the prognosis of unresectable HCC patients receiving first-line Lenvatinib or atezolizumab plus bevacizumab 34
Germline testing and genetic counseling in biliary tract cancer: an operative proposal to improve the state of art 30
Novel prognostic biomarkers of mucosal healing in ulcerative colitis patients treated with anti-Tnf: Neutrophil-To-lymphocyte ratio and platelet-To-lymphocyte ratio 27
Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study 23
The transcription factor HIF2α partakes in the differentiation block of acute myeloid leukemia 21
Tissue- and liquid biopsy-based biomarkers for immunotherapy in breast cancer 21
Impact of metformin, statin, aspirin and insulin on the prognosis of uHCC patients receiving first line Lenvatinib or Atezolizumab plus Bevacizumab 11
Totale 244
Categoria #
all - tutte 1.641
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 1.641


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 1 0 0 0 0 0
2022/202316 2 3 0 2 2 1 1 0 2 3 0 0
2023/202442 0 1 5 2 5 4 0 0 0 2 8 15
2024/2025185 18 4 3 13 20 19 30 49 21 8 0 0
Totale 244